No insider purchase over the last 90 days. The latest, by Tranchina Benjamin, was filed 23 May 2019.
This page follows insider dealings at Nuvectra Corp as filed with SEC (Form 4). The past year has been quiet: not a single insider filing for Nuvectra Corp. The previous disclosure was published on 26 December 2019.
The full history, which starts in 2016, counts 22 purchases against 8 sales.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2018 · cache
25 of 226 declarations
Nuvectra Corp is a company focused on developing medical technologies for pain management. It is listed on NASDAQ under the ticker NVTR.
Purchases our model currently ranks for the recommendations list.
All recommendations